antiviral therapy
Remdesivir + Corticosteroids Boost Survival in COVID-19 Patients With COPD
Early initiation of remdesivir (Veklury, Gilead Sciences) and corticosteroids in patients with COPD and COVID-19 ...
AUGUST 8, 2025
Ensitrelvir Reduces COVID-19 Risk by 67%
Ensitrelvir, an antiviral being developed to prevent COVID-19, reduced the risk of developing the infection by 67% ...
APRIL 24, 2025
Government, Community Health Organizations Support Continued Access to COVID-19 Care
HHS has announced that it will work with pharmacies, insurers and health systems to make sure that all Americans ...
MARCH 5, 2024
COVID-19 Antivirals Are No Longer Free—What Now?
HHS announced a plan to smooth the transition to traditional ordering, distribution and payment for COVID-19 ...
DECEMBER 24, 2023
Study Sees Vast Undertreatment for HBV
Nearly half of all treatment-eligible patients infected with chronic hepatitis B do not receive treatment for the ...
FEBRUARY 25, 2021
FDA Approves Xofluza for Influenza
Xofluza is indicated for the treatment of acute uncomplicated influenza in patients aged 12 years and older who ...
OCTOBER 24, 2018
